Back
Sagimet Biosciences 10K Form
Buy
65
SGMT
Sagimet Biosciences
Last Price:
4.88
Seasonality Move:
64.91%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SGMT News And Ratings
See the #1 stock for the next 7 days that we like better than SGMT
SGMT Financial Statistics
Sales & Book Value
Annual Sales: | $2M |
---|---|
Cash Flow: | $-19.57M |
Price / Cash Flow: | 0 |
Annual Sales: | $5.30 |
Price / Book: | 0.92 |
Profitability
EPS (TTM): | -1.28600 |
---|---|
Net Income (TTM): | $-37.52M |
Gross Margin: | -- |
Return on Equity: | 0% |
Return on Assets: | 0% |
Sagimet Biosciences Earnings Forecast
Key Sagimet Biosciences Financial Ratios
- The Research & Development expenses have been 988.85% of Revenue.
- The Interest Expense is 0.00% of Operating Income.
- Per Share Earnings over the last 5 years have been positive in 1 years.
Sagimet Biosciences Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | NASDAQ |
---|---|
Industry: | Biotechnology |
Sector: | Health Care |
Current Symbol: | SGMT |
Website: | sagimet.com |
Debt
Debt-to-Equity Ratio: | 0 |
---|---|
Current Ratio: | 0 |
Quick Ratio: | 0 |
Price-to-Earnings
Trailing P/E Ratio: | 0 |
---|---|
Forward P/E Ratio: | 0 |
SGMT Technical Analysis vs Fundamental Analysis
Buy
65
Sagimet Biosciences (SGMT)
is a Buy
Is Sagimet Biosciences a Buy or a Sell?
-
Sagimet Biosciences stock is rated a Buy
The current Sagimet Biosciences [SGMT] share price is $4.89. The Score for SGMT is 65, which is 30% above its historic median score of 50, and infers lower risk than normal.